Jochen H. Lorch, MD, MS
Advertisement
Articles by Jochen H. Lorch, MD, MS
A key opinion leader reviews the case of a 71-year-old woman with NTRK gene fusion thyroid cancer and considers novel therapies available for the management of her disease.
Advertisement
Latest Updated Articles
Preferred Testing Methods and Treatment OptionsPublished: September 21st 2020 | Updated:
- LOXO-101 Trial Regimen Overview
Published: September 21st 2020 | Updated:
- A 71-Year-Old Woman With NTRK Gene Fusion Thyroid Cancer
Published: September 21st 2020 | Updated:
- NTRK Gene Fusion Thyroid Cancer: Incidence and Prognosis
Published: September 21st 2020 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
